Without scientist Kseniia Petrova’s expertise, no one can fully unlock the data’s potential, putting crucial advancements in early cancer detection at risk.
Looking at a couple publications from the lab funding appears to be from a couple different foundations but nothing commercial. Pharma barely puts anything into basic R+D unless they’re a startup. Established pharma R+D is largely clinical trials and/or process development. If her work is patented by the university then pharma may pay the university to use her work. University would then give a smaller kickback to the lab/scientists.
NCI (national cancer institute-part of NIH) was the largest cancer research funder in the US, about 7B worth and even then less than 10% of proposed projects were being funded. The ACS (American cancer society) funds about 100M.
Thank you for this. I’m not sure how it became common knowledge to assume pharma companies pay for r&d but I’ve seen 10 different people on this app say those exact words and it’s really starting to peeve me off.
Looking at a couple publications from the lab funding appears to be from a couple different foundations but nothing commercial. Pharma barely puts anything into basic R+D unless they’re a startup. Established pharma R+D is largely clinical trials and/or process development. If her work is patented by the university then pharma may pay the university to use her work. University would then give a smaller kickback to the lab/scientists.
NCI (national cancer institute-part of NIH) was the largest cancer research funder in the US, about 7B worth and even then less than 10% of proposed projects were being funded. The ACS (American cancer society) funds about 100M.
Thank you for this. I’m not sure how it became common knowledge to assume pharma companies pay for r&d but I’ve seen 10 different people on this app say those exact words and it’s really starting to peeve me off.